Skip to main content
. 2022 Jan 15;28(11):1687–1695. doi: 10.1093/ibd/izab339

Table 1.

Proportion of COVID-19 in patients with IBD by population size and number of COVID-19 cases in the population stratified by continents and quadrants within the United States: March 13, 2020 to July 31, 2021.

COVID-19 Cases Reported in the SECURE-IBD Registry COVID-19 Cases Reported in the Countries or States Reporting in the SECURE-IBD Registry Proportion of COVID-19 Cases reported to the SECURE-IBD (per 100 000)
World∗∗ 6,404 178,155,029 3.59 (3.51, 3.68)
Africa 29 3,944,809 0.74 (0.49, 1.06)
Asia 412 50,300,051 0.82 (0.73, 0.90)
Europe 3,110 48,398,556 6.43 (6.20, 6.66)
Latin America 342 39,057,623 0.47 (0.76, 0.97)
North America 2,416 36,416,733 6.63 (6.37, 6.90)
Oceania 13 37,257 34.89 (18.58, 59.66)
United States∗∗∗ 2,231 34,817,970 6.41 (6.14, 6.68)
Midwest 681 7,495,739 9.09 (8.42, 9.79)
Northeast 596 5,843,208 10.20 (9.40, 11.05)
South 629 13,823,528 4.55 (4.20, 4.92)
West 254 7,655,495 3.32 (2.92, 3.75)

∗Proportion of COVID-19 cases reported to the SECURE-IBD registry relative to all COVID-19 cases in the general population among countries or states reporting data into the SECURE-IBD registry (per 100,000).

∗∗826 reported cases of COVID-19 in patients with IBD did not report the country of origin.

∗∗∗Five reported cases of COVID-19 in patients with IBD were from United States territories outside of the 4 regions listed here.